Characteristics of Glioma stiffness and its effect on drug resistance of Gliom

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047750

Enrollment

Unknown

Registered

2021-06-26

Start date

2021-08-24

Completion date

Unknown

Last updated

2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

Case series:No

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria More than 2 pathologists re-read the pictures together and confirmed the diagnosis as glioma.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

Measure	Time frame
Stiffness;immunofluorescence;immunohistochemistry;	—

Countries

China

Contacts

Public ContactPing Yifang

The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University

pingyifang@126.com+86 18623448461

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026